Page last updated: 2024-10-25

eflornithine and Allodynia

eflornithine has been researched along with Allodynia in 2 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
" Increasing the dosage of the immunotherapeutic increased the magnitude (intensity and duration) of the pain behavior."1.56Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO. ( Diccianni, MB; Gangoti, JA; Kempińska, K; Sorkin, LS; Yu, AL, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Diccianni, MB1
Kempińska, K1
Gangoti, JA1
Yu, AL1
Sorkin, LS1
Geng, Z1
Ming, B1
Hu, S1
Dong, L1
Ye, C1

Other Studies

2 other studies available for eflornithine and Allodynia

ArticleYear
Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO.
    PloS one, 2020, Volume: 15, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Eflornithine; Gangliosides; Hyperalgesia; Ma

2020
α-Difluoromethylornithine suppresses inflammatory arthritis by impairing myeloid-derived suppressor cells.
    International immunopharmacology, 2019, Volume: 71

    Topics: Adoptive Transfer; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Experimenta

2019